Horace Mann Educators heads into its May 5 Q1 earnings call with a stock that has climbed 8.5% over the past month — and a CEO who just pocketed $346,000 at the top of that move.
The most pointed signal this week is the insider trade. CEO Marita Zuraitis sold 7,500 shares on April 23 at $46.16, just a day before the stock shed half a percent to close at $45.88. The timing sits squarely at the high end of a month-long rally. She received a substantial stock award in early March — 63,056 shares — so the context is important: this looks more like routine harvest than a conviction exit. But the sale is the loudest insider signal in months, and it arrived as the stock approached a ceiling analysts have been eyeing.
The Street's positioning is cautious rather than bearish. The consensus sits at hold, with a mean price target of $51.50 — implying roughly 12% upside from current levels. The most recent analyst actions on record are dated to mid-2025: BMO Capital launched coverage at Outperform with a $48 target, while Raymond James reiterated Strong Buy with a $49 target. Piper Sandler has held Neutral throughout, most recently at $45. That puts HMN trading at a modest premium to the neutral camp but still below the optimistic end. At a trailing P/E near 9.5x and price-to-book of 1.09, the valuation is undemanding for an insurance name, and the forward yield of 3.1% provides some cushion. Factor scores paint a mixed picture: the dividend score ranks at the 92nd percentile, reflecting the company's consistent payout history, but EPS momentum is weak — ranking 24th percentile on a 30-day basis and just 13th over 90 days. Analysts have not lifted forward estimates meaningfully, and the EPS surprise rank sits at the 36th percentile.
Short interest tells a less dramatic story than the one-month change implies. At 2.2% of the float, shorts are a small presence — but that figure has climbed roughly 41% over the past month, adding around 150,000 shares to what was a very lightly shorted name. The jump happened in a single step around April 9-10, when estimated short interest moved from roughly 777,000 shares to 887,000 and has stayed there. Cost to borrow more than doubled over the week to 1.03%, a notable spike for a stock that was borrowing at around 0.45% through most of April. Availability in the lending pool is loose by any standard — the borrow market shows no sign of squeeze pressure. Days to cover is under two. This is not a heavily contested short, but the steady creep of new shorts being added into the price strength is worth noting.
The options market adds little texture here. The put/call ratio has been effectively zero for all but a handful of days in the past six weeks, reflecting thin options activity on this name. The 52-week high on the PCR was 2.35, suggesting occasional hedging bursts, but right now there is no options-based signal to read.
Looking at the peer group, HMN held up better than most this week. THG, HIG, and ALL each fell 0.8–1.9% on the week, while HMN gained 1.2%. The relative outperformance is notable given the CEO sale and the approaching earnings date. The Q1 print on May 5 follows a run of negative one-day post-earnings reactions — the last four results days all produced declines ranging from 0.6% to 4.5%, with five-day drifts averaging around 4-5% lower. What the next print is really being asked to answer is whether the margin improvements in property-casualty and supplemental benefits that the bull case rests on have continued against a backdrop of weaker-than-expected EPS momentum heading into the quarter. The teacher-focused distribution story and last week's Teacher Appreciation Month campaign signal the company is leaning into its niche brand — how that translates into premium growth and retention will be the number investors watch most closely on May 5.
See the live data behind this article on ORTEX.
Open HMN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
